０７６萌ＳＮＳ
  • Login

  • Public

    • Public
    • Network
    • Groups
    • Popular
    • People

Conversation

Notices

  1. Ars Technica (arstechnica@mastodon.social)'s status on Saturday, 12-Oct-2024 20:03:09 JST Ars Technica Ars Technica

    Why a diabetes drug fell short of anticancer hopes

    Studies suggested it could treat cancer, but the clinical trials were a bust.

    https://arstechnica.com/health/2024/10/why-a-diabetes-drug-fell-short-of-anticancer-hopes/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social

    In conversation about 2 months ago from mastodon.social permalink

    Attachments


    1. https://files.mastodon.social/media_attachments/files/113/294/113/733/516/302/original/2fde7f044240d9f7.jpg

    Feeds

    • Activity Streams
    • RSS 2.0
    • Atom
    • Help
    • About
    • FAQ
    • TOS
    • Privacy
    • Source
    • Version
    • Contact

    ０７６萌ＳＮＳ is a social network, courtesy of ０７６. It runs on GNU social, version 2.0.2-beta0, available under the GNU Affero General Public License.

    Creative Commons Attribution 3.0 All ０７６萌ＳＮＳ content and data are available under the Creative Commons Attribution 3.0 license.